Biggest News Aggregation in the World
📰 Cochlear Limited News

Page 4 - Cochlear Limited News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cochlear Limited. Real-time updates on events, politics, business and more.

Insider Buying: Cochlear Limited (ASX:COH) Insider Purchases 138 Shares of Stock

Cochlear Limited (ASX:COH – Get Free Report) insider Karen Penrose acquired 138 shares of the business’s stock in a transaction dated Wednesday, October 18th. The stock was acquired at an average price of A$252.80 ($160.00) per share, for a total transaction of A$34,885.99 ($22,079.74). Karen Penrose also recently made the following trade(s): On Tuesday, September […]
New South Wales Karen Penrose Cochlear Limited Cochlear Company Profile Get Free Report Cochlear Daily

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cochlear Limited (OTCMKTS:CHEOY) Sees Large Decline in Short Interest

Cochlear Limited (OTCMKTS:CHEOY – Get Free Report) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 3,700 shares, a decline of 79.3% from the September 15th total of 17,900 shares. Based on an average daily volume of 16,800 shares, the days-to-cover ratio is […]
New South Wales Morgan Stanley Cochlear Limited Get Free Report Cochlear Daily Otcmkts Cheoy

Cochlear Limited (OTCMKTS:CHEOF) Short Interest Down 13.6% in September

Cochlear Limited (OTCMKTS:CHEOF – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 85,300 shares, a drop of 13.6% from the August 31st total of 98,700 shares. Based on an average trading volume of 1,100 shares, the short-interest ratio is […]
New South Wales Cochlear Company Profile Cochlear Limited Get Free Report Cochlear Daily Otcmkts Cheof

Sensorion Announces the Availability of Its Financial Report for the 1st Half of 2023

26.09.2023 - Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, Sensorion ...
Lang Schwarz Professeur Joseph Blayac Institut Pasteur Half Financial Report Financial Information Cochlear Limited

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science